Uso de tecnologías de la información y comunicación por pediatras argentinos / Use of information and communication technologies by argentine pediatricians

Introducción: No existen datos en la Argentina acerca de la adopción de tecnologías de información y comunicación (TIC) por parte de los pediatras. Objetivos: Estimar la prevalencia de uso de historia clínica electrónica (HCE) y de mensajería electrónica. Describir percepción de ventajas y desventajas. Población y métodos: Estudio observacional, exploratorio, descriptivo y transversal. Se envió una encuesta autoadministrada al padrón de socios de la Sociedad Argentina de Pediatría entre julio y septiembre de 2017. Resultados: De 14.604 socios, se recibieron 3468 respuestas (el 23,7 %); 2680 fueron completas (el 18,4 %). El porcentaje de uso de HCE fue del 44 %. Se destacaron ventajas: acceso a la información (el 23,2 %), agilización del trabajo (el 20,1 %), resguardo seguro de información (el 14,3 %), disponibilidad (el 11,9 %), cálculo de percentiles (el 11,1 %) y realización de estadísticas (el 9,2 %). Las desventajas percibidas fueron cuestiones técnicas (el 32 %), temor a pérdida de información (el 20 %), dudas sobre cuestiones legales (el 15,8 %). El 49,8 % consideró implementar el uso de HCE en el próximo año.El 76,9 % usaba aplicaciones para recibir consultas de sus pacientes. El WhatsApp (el 46,6 %) fue la plataforma más utilizada. El 74 % consideraba que las consultas no presenciales deberían ser remuneradas. Conclusión: El 44 % de los pediatras que respondieron utilizaba HCE. El 49,8 % consideró implementar algún sistema de HCE durante el año siguiente al estudio. La mensajería electrónica era ampliamente utilizada (el 76,9 %) en todos los rangos etarios.

Introduction: There are not data in Argentina about the percentages of use of Information and Communication Technologies by pediatricians yet. Objectives: To estimate the prevalence of the use of Electronic Health Records (EHR) and Electronic Messaging. To describe the perception of advantages and disadvantages. Population and methods: Observational, exploratory, descriptive and transversal study. Five submissions of a self-administered survey were made to the list of partners of the Sociedad Argentina de Pediatría between July and September of 2017. Results: Of 14,604 partners, 3468 responses were received (23.7 %); 2680 were complete (18.4 %). The overall percentage of use of EHR was 44 %. There were advantages: access to information (23.2 %), streamlining work (20.1 %), secure information backup (14.3 %) and availability (11.9 %), calculation of percentiles (11.1 %) and statistics (9.2 %). The perceived disadvantages: technical issues (32 %), fear of information loss (20 %), doubts about legal issues (15.8 %). The use of EHR was going to be implemented by 49.8 % of respondents in the next year. Applications to receive consultations from their patients were used by 76.9 % of pediatricians. WhatsApp (46.6 %) was the most integrated platform. It was considered by 74 % that non face to face consultations should be remunerated. Conclusion: EHR was used by 44 % of pediatricians who responded. And 49.8 % were considering the implementation of some EHR system during the next year. Electronic messaging was widespread (76.9 %) in all age ranges.

Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina

This study aimed to evaluate well-documented diagnostic antigens, named B13, 1F8 and JL7 recombinant proteins, as potential markers of seroconversion in treated chagasic patients. Prospective study, involving 203 patients treated with benznidazole, was conducted from endemic areas of northern Argentina. Follow-up was possible in 107 out of them and blood samples were taken for serology and PCR assays before and 2, 3, 6, 12, 24 and 36 months after treatment initiation. Reactivity against Trypanosoma cruzi lysate and recombinant antigens was measured by ELISA. The rate of decrease of antibody titers showed nonlinear kinetics with an abrupt drop within the first three months after initiation of treatment for all studied antigens, followed by a plateau displaying a low decay until the end of follow-up. At this point, anti-B13, anti-1F8 and anti-JL7 titers were relatively close to the cut-off line, while anti-T. cruzi antibodies still remained positive. At baseline, 60.8% (45/74) of analysed patients tested positive for parasite DNA by PCR and during the follow-up period in 34 out of 45 positive samples (75.5%) could not be detected T. cruzi DNA. Our results suggest that these antigens might be useful as early markers for monitoring antiparasitic treatment in chronic Chagas disease.